Avandia Safety Being Reconsidered By FDA Panel

Despite GlaxoSmithKline saying it does not plan to make almost-discontinued diabetes drug Avandia available in the USA, the FDA's Endocrinologic and Metabolic advisory panel along with the FDA's Drug Safety and Risk Management Advisory committee will consider the medication's safety in June 2013. In September 2010, the FDA (Food and Drug Administration) severely restricted Avandia usage, and ordered GlaxoSmithKline to convene an independent group of scientists to re-check data on the drug's clinical trials...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Diabetes Source Type: news